Additionally, a lot of well recognized adverse prognostic markers, which includes U-CLL, ATM aberrations or NOTCH1/BIRC3 mutations, shed their unfavorable result in people handled with VO. The sole issue that remained predictive of the shorter progression-absolutely free survival in this cohort of individuals was TP53 aberrations.112 Last but not l